EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Changing the location of proteins on the cell surface is a promising strategy for modulating T cell functions

Marianne Strazza, Ruijiang Song, Shannon Hiner iD, Adam Mor iD

Immunology · 2024

DOI: 10.1111/imm.13828 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, 2024. Verfasst von Marianne Strazza und 3 weiteren Autor:innen. Beteiligte Einrichtung: Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Immunological Synapses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health (USA), NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting immune receptors on T cells is a common strategy to treat cancer and autoimmunity. Frequently, this is accomplished through monoclonal antibodies targeting the ligand binding sites of stimulatory or inhibitory co‐receptors. Blocking ligand binding prevents downstream signalling and modulates specific T cell functions. Since 1985, the FDA has approved over 100 monoclonal antibodies against immune receptors. This therapeutic approach significantly improved the care of patients with numerous immune‐related conditions; however, many patients are unresponsive, and some develop immune‐related adverse events. One reason for that is the lack of consideration for the localization of these receptors on the cell surface of the immune cells in the context of the immune synapse. In addition to blocking ligand binding, changing the location of these receptors on the cell surface within the different compartments of the immunological synapse could serve as an alternative, efficient, and safer approach to treating these patients. This review discusses the potential therapeutic advantages of altering proteins' localization within the immune synapse and summarizes published work in this field. It also discusses the novel use of bispecific antibodies to induce the clustering of receptors on the cell surface. It presents the rationale for developing novel antibodies, targeting the organization of signalling receptor complexes on the cell surface. This approach offers an innovative and emerging technology to treat cancer patients resistant to current immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesImmunological SynapsesHumansAnimalsSignal TransductionNeoplasmsAntibodies, MonoclonalCell MembraneAntibodies, BispecificReceptors, Immunologic

Stichwörter der Autor:innen

T cellsbispecific antibodiescancer immunotherapyimmune checkpointsimmune synapse

Substanzen

Antibodies, MonoclonalAntibodies, BispecificReceptors, Immunologic

Autor:innen und Institutionen

  • Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
  • Division of Rheumatology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.

ORCID-Profile: Shannon Hiner, Adam Mor

Förderung

  • National Institutes of Health (USA)
  • NCI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Strazza, M., Song, R., Hiner, S., & Mor, A. (2024). Changing the location of proteins on the cell surface is a promising strategy for modulating T cell functions. Immunology. https://doi.org/10.1111/imm.13828

Vancouver

Strazza M, Song R, Hiner S, Mor A. Changing the location of proteins on the cell surface is a promising strategy for modulating T cell functions. Immunology. 2024. doi:10.1111/imm.13828

BibTeX
@article{Strazza2024,
  author = {Strazza, Marianne and Song, Ruijiang and Hiner, Shannon and Mor, Adam},
  title = {Changing the location of proteins on the cell surface is a promising strategy for modulating T cell functions},
  journal = {Immunology},
  year = {2024},
  doi = {10.1111/imm.13828}
}
Kostenlos starten →